Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ Cells

NCT02797470 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT02797470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02797470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-Selected CD34+ Cells
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
June 23, 2016
Completion date
March 31, 2036
Enrollment
11 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, mature t-cell and nk-cell non-hodgkin lymphoma, plasmablastic lymphoma, recurrent adult hodgkin lymphoma, recurrent adult non-hodgkin lymphoma, recurrent burkitt lymphoma, recurrent follicular lymphoma, stage iii follicular lymphoma, stage iii mantle cell lymphoma, stage iv follicular lymphoma, stage iv mantle cell lymphoma